A detailed history of Vida Ventures Advisors, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Vida Ventures Advisors, LLC holds 407,499 shares of DYN stock, worth $10 Million. This represents 17.16% of its overall portfolio holdings.

Number of Shares
407,499
Previous 407,499 -0.0%
Holding current value
$10 Million
Previous $14.4 Million 1.79%
% of portfolio
17.16%
Previous 25.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$13.06 - $29.18 $21.8 Million - $48.7 Million
-1,667,288 Reduced 80.36%
407,499 $11.6 Million
Q4 2023

Jan 05, 2024

SELL
$6.62 - $13.64 $961,535 - $1.98 Million
-145,247 Reduced 6.54%
2,074,787 $27.6 Million
Q3 2022

Oct 05, 2022

SELL
$7.2 - $15.17 $5.33 Million - $11.2 Million
-740,012 Reduced 25.0%
2,220,034 $28.2 Million
Q3 2020

Nov 12, 2020

BUY
$20.0 - $23.9 $59.2 Million - $70.7 Million
2,960,046 New
2,960,046 $59.8 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.27B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Vida Ventures Advisors, LLC Portfolio

Follow Vida Ventures Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vida Ventures Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vida Ventures Advisors, LLC with notifications on news.